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This study focuses on the long stretch of highly conserved amino acids in the membrane proximal part of
the HIV-1 cytoplasmic tail (Env amino acids (aa) 706–718) upstream of the overlap with the tat and rev
second coding exons. Changes in Env aa 713 and 715, although they did not affect Env function, abrogated
replicative spread. Other amino acid substitutions, i.e., 706–712, 714 and 716, despite their conservation,
did not result in defective replicative phenotypes even in primary peripheral blood lymphocytes. Our
results point to their involvement in presently unrecognized essential Env functions pertinent only in
in vivo. Interestingly, changes in the codons for residues 717–718 as well as some mutations in residues
714–716 abrogated Gag expression but still allowed expression of functional Env in a rev-independent
manner. This could be due to the inactivation of a rev-regulated negative element within the respective
nucleotide sequence (8354–8368).
& 2013 Elsevier Inc. All rights reserved.Introduction
A conserved feature of most lentiviral glycoproteins, including
the Env glycoprotein of human immunodeﬁciency virus type 1
(HIV-1), is the presence of a very long cytoplasmic tail region (Env-
CT) which, in the case of HIV, is 151 amino acids (aa) long. The
properties of the HIV Env-CT and its contributions to essential viral
functions have been extensively studied. They are summarized in
recent reviews (Checkley et al., 2011; Postler and Desrosiers, 2013)
and will only be brieﬂy described here. Thus, the Env-CT, pre-
sumably mediated by its interaction with the viral matrix protein
(MA), has been proposed to play roles in Env incorporation into
virions (Freed and Martin, 1996) and in the regulation of fusion
between released virions and the membrane of target cells
(Murakami et al., 2004; Wyma et al., 2004). Several structural
and functional motifs are located within the region. Most promi-
nent of these are three so-called lentiviral lytic peptide (LLP1-3)
motifs located in the central and C-terminal region of the Env-CT.
These motifs have been shown to interact with cellular mem-
branes and have been proposed to be involved in multiple Env-
mediated functions (for review, see Checkley et al. (2011)). Two
functional endocytosis motifs are also located in the Env-CT,ll rights reserved.
).
e (V. Bosch).namely a membrane-proximal tyrosine-based signal (YxxL) and a
C-terminal dileucine motif (Env-LL855,856), both of which operate
independently through interaction with clathrin adaptor protein
complexes (Berlioz-Torrent et al., 1999; Byland et al., 2007; Wyss
et al., 2001). The membrane-proximal YxxL motif has also been
shown to play a role in the basolateral targeting of Env (and Gag)
in polarised cells (Lodge et al., 1994; Lodge et al., 1997).
Mutational analysis of the Env-CT has been quite extensive and
the phenotypes of mutant virions carrying a wide variety of point
mutations and internal and C-terminal deletions in the Env-CT
have been analysed. Perhaps surprisingly, the Env-CT region is
actually dispensable for replication in certain laboratory-derived
cell lines but its presence is absolutely essential for replicative viral
spread in most T-cell lines and in primary PBMCs (Murakami and
Freed, 2000b). The existence of an HIV Env-CT region is extremely
highly conserved in vivo and, in the simian immunodeﬁciency
virus/monkey model, truncation of the Env-CT led to suppression
of viral replication in vivo (Shacklett et al., 2000).
The functional roles currently attributed to the long HIV-Env-
CT can, however, be fulﬁlled by the glycoproteins of other retro-
viruses (apart from lentiviruses), as well by the glycoproteins of
enveloped viruses in general, all of which carry much shorter CT
regions. This suggests that additional lentiviral Env-CT functions,
essential for viral replication and pathogenesis in vivo, still remain
to be elucidated. One approach, which potentially promised to
yield information relevant to this, has been the identiﬁcation of
cellular proteins interacting with the Env-CT. In fact, several
conﬁrmed Env-CT interacting cellular proteins have been found
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novel Env-CT functions (for review, see Checkley et al. (2011)).
The mutational analyses on the HIV Env-CT carried out to date,
have frequently focussed on identiﬁable structural or functional
motifs, e.g., on the LLP1-3 domains or on motifs implicated in
endocytosis, sorting or potential post-translational modiﬁcation
(e.g., cysteine palmitylation). One of the longest stretches of highly
conserved amino acids within the Env-CT domain is the section of
13 residues immediately proximal to the viral membrane and
preceding the overlap with the reading frames for the rev and tat
second coding exons. The presence of the membrane-proximal
tyrosine-based endocytosis signal as well as nucleotide sequence
restriction required for functional splicing at splice acceptor 7
(SA7) may contribute to this conservation. Nevertheless, since it
would appear that neither of these occurrences would require the
high conservation observed, we have performed extensive muta-
tional analysis of the region and analysed the phenotypes of the
respective mutants with respect to Env function and viral
replication.Results
Properties of mutant virions with alanine replacements
The ﬁrst 13 aa (residues 706–718) of the HIV Env cytoplasmic
tail (Env-CT), i.e., the region directly following the Env-TMD and
thus adjacent to the membrane, represents one of the longest
stretches of conserved aa within the Env-CT domain. In Fig. 1A, the
sequence of these aa in the Env protein of the HIV-1 strain BH10
(Ratner et al., 1985) is shown and the percentage conservation of
each residue is given as evaluated using the Quickalign tool with
reference to the 2011 web alignment provided by the HIV
Database, Los Alamos, New Mexico, USA (http://www.hiv.lanl.
gov/). Ten of 13 residues exhibit >95% conservation, Q710 is
91.5%, N706 is 88.1% and F717 is 82.3% conserved. The percentage
conservation of the neighbouring aa (residues 702–705 and 719–
721), which were included in this study, is also shown. In order to
gain information as to the possible functional roles of the mem-
brane proximal Env-CT region, extensive mutational analysis was
performed. In a ﬁrst set of mutants, Env aa 702–721 were changed
in groups of 3 (in one case 2), in all cases to alanine, except in the
case of THL719–721 which were mutated to ILH (thus maintaining
the aa sequence of the overlapping Rev protein) (Fig. 1A). HEK 293
T cells were transfected with pNL-Wt and the respective mutant
constructs. Fig. 1B shows Western blot analysis of cell-associated
Env (gp160/gp120 and gp41) and Gag (p24 is shown, its amounts
reﬂects the amounts of expressed intracellular Gag proteins
(Pr55gag and cleavage products)). Env proteins were generated
in all cases and proteolytically processed to gp120 and gp41. As
determined by immunoblot of cell lysates (Fig. 1B) and CA-ELISA of
released virions in culture supernatants (not shown), Gag proteins
were also generated in equal amounts in all cases except in the
cases of pNL-Env-714–716–AAA and pNL-Env-717–718–AA where
no p24 was detectable at all. As will be discussed later (Fig. 2), this
is due to functional destruction of the splice acceptor 7 (SA7)
sequence.
The Wt and all of the mutant Env proteins exhibited cell–cell
fusion activities (reﬂecting the sum of Env cell surface expression
level and fusion ability) when expressed in transfected HEK 293 T
cells, cocultivated with CD4/coreceptor expressing Tzm-bl reporter
cells. The extents of cell–cell fusion were equivalent to Wt in all
cases except in the cases of pNL-Env-714–716-AAA and pNL-Env-
717–718-AA which were reproducibly reduced to about 50% of Wt
(Fig. 1C). This reduction may be due to altered cell surface
expression in the absence of coexpressed Gag.Fig. 1D (top) shows the relative infection levels in Tzm-bl
reporter cells of Wt and mutant virions released into the super-
natants of transfected HEK 293 T cells. Three of the mutants (pNL-
Env-702–704-AAA, pNL-Env-705–707-AAA and pNL-Env-719–
721-ILH) exhibited infection levels equal to, or more than, Wt,
two mutants (pNL-Env-708–710-AAA, pNL-Env-711-713-AAA)
exhibited reduced infection levels and, as to be expected, there
was no detectable infection levels in the supernatants lacking
expressed Gag protein (pNL-Env-714–716-AAA, pNL-Env-717–718-
AA). In Fig. 1D, bottom, the abilities of the same virions to achieve
spreading infection in H9 T-cells is shown. To analyse this, cells
were infected at very low MOI with equal amounts of cell-free
virions and stained with anti-HIV serum on days 1, 2, 4, 6 and 7 p.
i.. Virions which resulted in 100% positive H9 T-cells on 7 day p.i.
were scored as infectious (+). Virions which are scored as (−−)
exhibited no or only a very low percentage of positively stained H9
T-cells on day 7. In general, those mutants with Wt infection levels
in Tzm-bl cells achieved spreading infection in H9 T-cells and
those lacking, or with clearly reduced, Tzm-bl infection levels
could not achieve spreading infection (Fig. 1D). An exception was
mutant pNL-Env-708-710-AAA which, despite repeatedly exhibit-
ing reduced Tzm-bl infectivity, was still able to mediate spreading
infection in H9 T-cells.
Fig. 1E shows the gp120 content of released Wt and mutant
virus particles. Virions were generated in H9 T-cells since it has
been reported that Env protein incorporation into HIV particles is
cell-dependent (Akari et al., 2000; Murakami and Freed, 2000b).
Efﬁcient proviral expression in these cells was achieved by infec-
tion with VSV-G pseudotyped Wt and mutant virions produced in
HEK 293 T cells (virus production was, however, not possible in the
cases of mutants pNL-Env-714–716-AAA and pNL-Env-717–718-
AA, which fail to express Gag). Virus particles newly produced in
the H9 T-cells were collected and concentrated at 48 h post
infection. As can be seen in Fig. 1E, all of the analysed virions
incorporated approximately equal amounts of gp120 except pNL-
711–713-AAA which exhibited reduced gp120 content.
Effect of nucleotide changes affecting splice acceptor 7
The nucleotide changes in some of the mutants are close to
the splice acceptor site (SA7) for the rev and tat second coding
exons (downstream junction at nucleotide 8369 in pNL4-3).
Using the MaxEntScan tool (http://genes.mit.edu/burgelab/max
ent/Xmaxentscan_scoreseq_acc.html), it could be determined
that the splicing scores at SA7 in pNL-Env-714–716-AAA and
pNL-Env-717–718-AA were reduced to −8.43 and −14.52,
respectively, (in comparison to the Wt score of 7.15) whereas
there was no signiﬁcant change in the cases of the other
mutants (see summary in Table 2). Note that higher scores are
indicative of better splicing potential. In order to analyse SA7
splicing directly, diagnostic fragments spanning the SA7 site
were ampliﬁed by RT-PCR from HIV mRNAs expressed in
transfected HEK 293 T cells. The positions of the employed
primers within the HIV genome are shown in Fig. 2A. Two
different primer pairs amplifying fragments from 2 kb intronless
mRNA species (Fig. 2B, left panel) or from 4 kb intron-
containing mRNA species (Fig. 2B, right panel) were employed.
The assignment of ampliﬁed fragments to speciﬁc viral RNA
species has been carried out as described (Purcell and Martin,
1993) and these assignments are shown on the right. It can
clearly be seen that, in comparison to pNL-Wt, pNL-Env-714–
716-AAA and pNL-Env-717–718-AA did not display the normal
SA7-dependent splicing pattern but rather exhibited aberrant
products. On the other hand, pNL-Env-711–713-AAA, which had
a splicing score very close to that of Wt, maintained the Wt
splicing pattern. These data strongly point to a splicing defect
Fig. 1. Properties of virions mutated within the internal membrane proximal region of the Env-CT. (A) The sequence of Env residues 702–721 (the major focus has been on aa
706–718) and the percentage conservation of individual residues are shown. The arrows above indicate the border of the Env-TMD and CT domains and the arrow below the
border of splice acceptor 7 (SA7). The individually boxed groups of 3 (in one case 2) amino acids have been mutated to alanine (A) (except residues THL719–721 which have
been mutated to ILH). (B) Western blot analysis of lysates of HEK 293 T cells transfected with pNL-Wt and the indicated proviral constructs. The top portion of the ﬁlter has
been probed with anti-gp120 serum, the middle portion with gp41 antibodies (Chessie 8) and the bottom portion with p24 antibodies. (C) Cell–cell fusion activities of
mutant glycoproteins as percentage of the activity of pNL-Wt-Env. The average of two independent experiments is shown (the range of values is shownwithin the respective
bars). (D) Top: Infection levels of mutant virions in Tzm-bl indicator cells as percentage of the activity of pNL-Wt. A representative experiment from at least two independent
experiments (in the case of pNL-Env-707–710-AAA four independent experiments) is shown. Bottom: abilities to mediate spreading infection in H9 T-cells. +indicates
infection similar to pNL-Wt,—indicates absent or only minimal infection. 3 independent experiments were performed. E. Western blot analysis of virions released from
infected H9 T-cells. The top portion of the ﬁlter has been probed with anti-gp120 serum and the bottom portion with p24 antibodies. In B. and E., the positions of detected
HIV proteins are indicated on the right and of molecular weight markers on the left.
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the reason for the lack of Gag expression from pNL-Env-714–
716-AAA and pNL-Env-717–718-AA. Tat transactivation ability is
less likely to be impinged since exon 2 is not essential for this
function (Green and Loewenstein, 1988). As shown in Fig. 2C,
Gag expression from pNL-Env-714–716-AAA and pNL-Env-717–
718-AA could be completely restored when HIV- rev (and tat)
was provided in trans by cotransfection with the subviral
construct pLTR-ctat/crev. Virion particles were also released
into the medium (as established by CA-ELISA) but these were
only very poorly infectious in a single-round assay in Tzm-bl
cells (approx. 4% of pNL-Wt, data not shown). Thus the data inFig. 1B and Fig. 2C show that, in the cases of pNL-Env-714–716-
AAA and pNL-Env-717–718-AA, Env expression was indepen-
dent of functional SA7 splicing and thus presumably also of Rev
protein expression. To test this directly, we have additionally
introduced a stop codon in the rev reading frame (leaving the
overlapping env reading frame open) in the context of pNL-Env-
714–716-AAA (and pNL-Wt) and examined Env and Gag expres-
sion. As to be expected, in the case of pNL-Wt, lack of functional
Rev protein completely abrogated both Env and Gag expression.
On the other hand, Env expression from pNL-Env-714–716-AAA
was unaffected (Fig. 2D) and was thus occurring independently
of expressed Rev protein.
Fig. 2. Viral mRNA and protein expression from proviral constructs with abrogated SA7 splicing. (A) Schematic picture of the HIV-1 genome showing the relative positions of
the 5′splice sites (ss) (D1 to D4) and 3’ss (A1 to A7) within the viral 9 kb pre-RNA. The positions of the primers (#1544, #640, #3392) used in the RT-PCR analysis are
indicated by arrows (primer sequences are given in the material and methods section). LTR (long terminal repeat); RRE (Rev responsive element); TAR (trans-activation
response element). (B) RT-PCR ampliﬁed fragments from HIV mRNA species in lysates of HEK 293 T cells transfected with the indicated constructs. The primer pair #1544/
#3392 was used to amplify the 2 kb intronless mRNA species (left panel) and primer pair #1544/#640 to amplify the 4 kb intron-containing mRNA species (right panel). The
RT-PCR products were resolved by non-denaturating polyacrylamide gel electrophoresis and stained with ethidium bromide. DNA fragment size markers are present in lanes
M. The assignment of ampliﬁed fragments to speciﬁc viral RNA species has been carried out as described (Purcell and Martin, 1993) and these assignments are shown on the
left. (C) Western blot analysis of lysates of HEK 293 T cells transfected with the indicated plasmids without or with cotransfection of pLTR-ctat/crev as indicated. D. Western
blot analysis of lysates of HEK 293 T cells transfected with pNL-Wt and pNL-Env-714–716-AAA without or with an additional mutation in the rev gene (expressing truncated
Rev-Tr62 protein) as indicated. In both (C and D), the top portions of the ﬁlters have been probed with anti-gp120 serum, the middle portions with gp41 antibodies (Chessie
8) and the bottom portions with p24 antibodies. The positions of viral proteins are given on the left and of molecular weight markers on the right.
Fig. 3. Properties of further mutants with retained splicing abilities. (A) Western blot analysis of lysates of HEK 293 T cells transfected with pNL-Wt and the indicated
proviral constructs. The top portions of the ﬁlters have been probed with anti-gp120 serum, the middle portions with gp41 antibodies (Chessie 8) and the bottom portions
with p24 antibodies. The positions of detected HIV proteins are indicated in the middle and of molecular weight markers on the right. (B) Cell–cell fusion activities of mutant
glycoproteins as percentage of the activity of pNL-Wt-Env. The experiment shown is the average of 2 independent experiments (the range of values is shown within the
respective bars). (C) Top: Infection levels of mutant virions in Tzm-bl indicator cells as percentage of the activity of pNL-Wt. Bottom: abilities to mediate spreading infection
in H9 T-cells. +indicates infection similar to pNL-Wt,—indicates absent or only minimal infection. 3 independent experiments were performed. (D) Western blot analysis of
virions released from infected H9 T-cells. The top portion of the ﬁlter has been probed with anti-gp120 serum and the bottom portion with p24 antibodies. The positions of
detected HIV proteins are indicated on the left and of molecular weight markers on the right.
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Three of the mutants studied so far (pNL-Env-711–713-AAA, pNL-
Env-714–716-AAA and pNL-Env-717–718-AA) were defective, in two
cases as a result of abrogated SA7 splicing. We thus aimed to
generate further mutations, which allow assessment of the putative
importance of Env aa 711–718 for viral replication independent of
effects on SA7 splicing. Table 1 lists the mutations generated and the
respective SA7 splicing scores (these again calculated using the
MaxEntScan tool (http://genes.mit.edu/burgelab/maxent/Xmaxents
can_scoreseq_acc.html). The new mutations within aa 711–716 all
had little effect on splicing scores. However, most changes at F717
abrogated splicing and the selected mutation F717S still resulted in a
reduced splicing score from 7.15 to 5.58 (Table 1). It was not possible
to change residue 718 without negatively affecting SA7 splicing score.1,00E+04
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Fig. 4. Infection kinetics of pNL-Wt and mutant virions in activated human PBMCs.
HIV reverse transcriptase activities (reﬂecting the amounts of released virions) in the
media of infected activated PBMCs collected at different time points p.i. was quantitated
as described in the methods section. Picomole units of HIV-RT are given as a function of
time (in days). The identities of the virions analysed are given on the right.
Table 1
Mutations within Env aa 711–718.
The amino acid changes of the respective Env residues, the splice score at SA7
(MaxEntScan tool (http://genes.mit.edu/burgelab/maxent/Xmaxentscan_scorese
q_acc.html)) and the names of the generated mutants are given.The properties of these new mutant virions are shown in Fig. 3.
All the new mutant constructs expressed Gag protein as deter-
mined by Western blot (Fig. 3A) and CA-ELISA of culture super-
natants (not shown) whereas, as before, pNL-Env-714–716-AAA
and pNL-Env-717–718-AA failed to do so. The Gag amounts, were
equal except in the case of pNL-Env-717-S, which, in accordance
with its reduced splicing score, expressed only about one third of
the amount of released p24 as pNL-Wt. In fact, direct analysis of
SA7 splicing activity of pNL-Env-717-S by RT-PCR of HIV-mRNA
again revealed a pattern of products differing from those from
pNL-Wt although not as drastically as was the case for pNL-Env-
714–716-AAA and pNL-Env-717–718-AA in Fig. 2B (data not
shown). All the mutant constructs expressed proteolytically pro-
cessed Env proteins (Fig. 3A). In general, the mutants expressed
amounts of Env approximately equal to that of pNL-Wt. An
exception was pNL-Env-711-A, 713-A which in half of the experi-
ments performed (4 experiments) expressed less Env. The reason
for this variability is not clear. All of the mutant glycoproteins were
functional and able to mediate cell–cell fusion in most cases to
levels equal to or higher than Wt-Env (Fig. 3B). Again the two
mutant constructs pNL-Env-714–716-AAA and pNL-Env-717–718-
AA, which fail to express Gag, exhibited reduced cell–cell fusion
activities (to about 50% of Wt-Env). Infection levels in Tzm-bl
reporter cells are shown in Fig. 3C, top panel and the abilities of
the virions to achieve spreading infection in H9 T-cells in the
bottom panel. As before, pNL-Env-714–716-AAA and pNL-Env-
717–718-AA, with splicing defects, were non-infectious and this
was also the case for pNL-Env-717-S, which has a reduced SA7
splicing score and expresses less Gag protein. The mutants
pNL-Env-711–713-AAA, pNL-Env-711-A, 713-A and pNL-Env-713-A, which all share the S713A mutation, exhibited reduced infection
levels in Tzm-bl cells and did not mediate spreading infection in
H9 T-cells. This was also the case for mutant pNL-Env-715-S. All of
the other constructs exhibited levels of infection in Tzm-bl cells,
which were equal to pNL-Wt or slightly increased or decreased,
respectively, and all of these mutant virions could mediate
spreading infection in H9 T-cells. In Fig. 3D, incorporation of
gp120 into released virions generated in H9 T-cells is shown. In
all cases, gp120 incorporation occurred but was somewhat
reduced in the cases of pNL-Env-711–713-AAA, pNL-Env-711-A,
713-A and pNL-Env-713-A, the constructs which share the S713A
mutation and are replication-defective in H9 T-cells.
In order to analyse viral replication in a more relevant system
and to more closely follow replication kinetics, freshly prepared
activated human PBMCs were infected with equal amounts (as
determined by CA-ELISA) of Wt and mutant virions. After removal
of input virions and washing, the amounts of newly generated
virions released into the culture supernatants were determined by
quantiﬁcation of HIV reverse transcriptase activities at different
time points post-infection using the PCR-enhanced assay
described recently (Pizzato et al., 2009). Only those mutant virions
which had demonstrated spreading infection in H9 T-cells were
analysed (since only these are likely to exhibit infection in the
more stringent PBMC assay). As shown in Fig. 4, all of the
examined mutant virions exhibited infection of PBMCs with
kinetics which in all cases were similar to pNL-Wt.Discussion
Our chief focus in this study has been on the possible impor-
tance of the 13 membrane-proximal residues of the Env-CT (Env aa
706–718) for Env function and virus replication. Our initial muta-
tional analysis (in total of aa 702–721), in which groups of 3 (in one
case 2) aa were mutated to alanine, already indicated that the exact
sequence of aa 702–710 and of 719–721 did not affect Env synthesis
or function and did not inhibit mutant viral replication in activated
primary blood lymphocytes. On the other hand, the chosen muta-
tions between aa 711 and 718, although they did not inhibit Env
synthesis or function, as measured by the abilities to mediate cell to
cell fusion, did abolish viral replication in a T-cell line.
In the case of pNL-Env-711–713-AAA, this did not appear to be
due to a negative effect on splicing since Gag and Env proteins were
generated in the same amounts as Wt. However, as to expected
from their drastically reduced splicing scores, in the cases of both
pNL-Env-714–716-AAA and pNL-Env-717–718-AA, splicing at SA7 is
defective and spliced transcripts in transfected cells differed dra-
matically from those seen in pNL-Wt (Fig. 2A). The defective Gag
phenotype could be completely complemented when Rev protein
was provided in trans by coexpression from a subviral vector.
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tion, both mutant proviruses still led to expression of functional Env
proteins in a rev-independent manner. In fact mutation of rev, which
abrogated Gag and Env expression in the Wt context, did not reduce
Env expression in the context of pNL-Env-714–716-AAA. These
unexpected observations, although actually not within the original
focus of this study, demonstrate that the mode of Env expression in
mutants pNL-Env-714–716-AAA and pNL-Env-717–718-AA is funda-
mentally different from that of Wt. Previously it has been demon-
strated that a cis-acting motif, capable of repressing Env protein
expression in a subgenomic context, is present within a 254 nt long
sequence (restriction fragment HindIII-AvaI, nucleotide 8131–8383)
mostly upstream of SA7 (nucleotide 8369) (Emerman et al., 1989). It
is thus possible that the nucleotide point mutations in pNL-Env-
714–716-AAA and pNL-Env-717–718-AA destroy this putative motif.
If so, our data would narrow it down to a sequence of only 15
nucleotides (nucleotides 8354–8368), which functionally overlap
with the polypyrimidine tract of SA7. Recently U2AF65 protein has
been identiﬁed as one of the nuclear retention factors which bind to
intron-containing pre-mRNAs (Takemura et al., 2011). It is thus
plausible that the mutations within nucleotides 8354–8368 abolish
this binding thus alleviating the requirement for Rev to counteract
U2AF65-mediated retention of mutated 4 kb env-mRNAs. Intron-
containing 4 kb env-mRNAs are 5′-terminally spliced and are thus
loaded with at least one exon-junction complex which licenses such
pre-mRNAs for nuclear export (Le Hir et al., 2000; Luo and Reed,
1999). An exon-junction complex, however, is lacking on the
unspliced genomic viral RNA which is thus likely to be retained in
the nucleus in the absence of Rev. These postulates would explain
why Gag expression from pNL-Env-714–716-AAA and pNL-Env-717–
718-AA is abrogated whereas Env expression still occurs. Future
experiments will aim to clarify these issues.
In order to further analyse the importance of 711–718 for Env
function and viral infectivity, we aimed to generate further muta-
tions, which did not effect SA7 splicing. This was difﬁcult for F717
and the chosen change, F717S, resulted in a reduced splicing score,
a reduction in Gag expression to about 30% and rendered the
mutant virus non-infectious. It was impossible to change Q718
without affecting splicing. It has thus not been possible in this
study to evaluate the importance of the conservation of these two
aa residues for Env protein function. However, the 8 double and
single additional mutations within aa 711–716 all resulted in
expression of normal amounts of Gag and functional Env. In fact
mutant virions with changes in 4 of these positions (pNL-Env-711-
A, pNL-Env-712-A, pNL-Env-714-L and pNL-Env-716-L) replicated
in a T-cell line and showed replication kinetics similar to Wt in
activated PBMCs. On the other hand, all three mutant virions
encoding the Env substitution S713A (namely pNL-Env-711–713-
AAA, pNL-Env-711-A, 713-A and pNL-Env-713-A) as well as the
mutant virion encoding L715S exhibited reduced infectivities in
Tzm-bl reporter cells and lack of replicative spread in H9 T-cells.
All of the mutant virions encoding S713A exhibited a reduction
in Env incorporation into particles and this is presumably, at least
in part, the reason for their replication defects. The processes
leading to Wt HIV-Env incorporation into particles are still not
completely understood. However, most models propose a role of the
Env-CT domain either by direct or indirect interaction with Gag or by
cotargeting of Env to Gag assembly sites (see Checkley et al. (2011) for
review). A region spanning LLP2 has been implicated in directly
mediating Env-CT binding to Gag (MA) (Murakami and Freed, 2000a)
but many mutations and deletions outwith this region also reduce or
abrogate Env incorporation into particles (e.g., (Piller et al., 2000)). The
reasons for these latter incorporation defects are generally not known
and this is also true here in the case of pNL-Env-713-A. Possibly
minimal aberrant changes in mutant Env conformations may lead to
the observed reduced Env incorporation and replication phenotypes.
Table 3
Mutagenising oligonucleotides.
Env mutants Sequence
702–704-AAA GCTGTAGCTGCTGCAGTGAATAG
705–707-AAA CTTTCTGTAGCGGCTGCAGTTAGGCAGG
708–710-AAA GAATAGAGCTGCGGCGGGATAT
711–713-AAA GCAGGCAGCTGCACCATTATC
711-A GGCAGGCATATTCACCATTATC
711-A, 713-A GGCAGGCATATGCACCATTATC
712-A GGCAGGGAGCTTCACCATTATC
713-A GGCAGGGATATGCACCATTATC
714–716-AAA ATTCAGCAGCAGCGTTTCAGAC
714-L GATATTCACTATTATCGTTTCAG
714-L, 716-L GATATTCACTATTATTGTTTCAG
715-S GATATTCACCATCATCGTTTCAG
716-L GATATTCACCATTATTGTTTCAG
717–718-AA CCATTATCGGCTGCGACCCACCTCCC
717-S CATTATCGTCTCAGACCCACCTC
719–721-ILH GTTTCAGATCCTCCACCCAA
Rev mutant
Rev-Tr62 (Env L753S, L755V, I756S) CGGATCCTCAGCTGTTAGCTGGGACG
The names of the respective mutants and the sequence of the employed mutagen-
ising oligonucleotides are given. The mismatched nucleotides are underlined.
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wild type phenotypes with respect to Env-mediated cell–cell
fusion and Env incorporation but did not achieve replicative
spread in H9 T-cells. L715 is the critical large hydrophobic residue
in the membrane proximal YxxL endocytosis motif so that an
obvious explanation is that an effect on endocytosis could be the
reason for the replication defect of pNL-Env-715-S. On the other
hand, the fact that in this study mutant pNL-Env-712-A, in which
the essential tyrosine residue of the YxxL motif has been mutated,
was still replication-competent speaks against this hypothesis. In
numerous previous studies, the YxxL motif has been the focus of
extensive analyses and viruses, mutated at Y712, analysed both
with respect to Env localisation and virus infectivity. Most studies
support the view that, in the context of the full-length Env-CT,
destruction of the YxxL motif alone does not markedly alter Env
subcellular localisation but that Y712 mutations in combination
with mutation of the C-terminal 855, 856LL motif strongly
increases Env surface expression (e.g., (Byland et al., 2007)).
Concerning the replicative properties of Y712 mutants, depending
on the amino acid change, the Env sequence context and the cell
lines examined, differing results have been obtained. Thus, in
some studies mutation of Y712 led to impaired replicative spread
while in other studies, the respective mutant viruses replicated as
well as wild type (Bhakta et al., 2011; Day et al., 2006; Lambele
et al., 2007; West et al., 2002). At any rate, since in this study a
functional YxxL motif is not a prerequisite for viral replication, the
reason for the observed replicative defect of pNL-Env-715-S
remains unknown.
It is perhaps surprising that mutation of the majority of the
conserved membrane proximal Env-CT residues did not lead to
defective phenotypes even in primary PBMCs. Our focus had been
on aa 706–718 and, of these, aa 706–712, 714 and 716, although
highly conserved within all HIV-1 strains (Fig. 1A), could be
changed without abrogation of replicative properties. These
results demonstrate that in vivo in an infected immunocompetent
organism, critical viral features come to bear, which are dispen-
sable even in primary cells in vitro. These are very likely to include
targeting phenomena mediated by the membrane-proximal YxxL
motif. However, since the further residues 706–711, 714 and 715,
which have not been implicated in Env targeting, are also highly
conserved, the roles which they may play remains a subject of
speculation. For example, it is feasible that in some target cells
in vivo, e.g., resting T-cells, macrophages etc., Env functions may be
modulated by speciﬁcally expressed cellular proteins, which
necessitate amino acid conservation in this membrane-proximal
Env-CT region. On the other hand, it is possible that the conserva-
tion is, at least partially, driven by the necessity to maintain
optimal nucleotide sequence conservation crucial to maintain
secondary structures and signals required for regulatory ﬁne
tuning in vivo. These may be protein binding sites for additional
regulatory proteins acting in concert with U2AF65 and/or UAP56
involved in RNA splicing and/or nuclear export (Takemura et al.,
2011). On the other hand, as has become apparent recently (Watts
et al., 2009), RNA architecture and secondary structure is also
more globally important in governing native protein folding
during translation. Again it is possible that this ﬁne tuning is more
impinged on in vivo. Experiments in the future may eventually
throw some light on these issues.Materials and methods
Mutational analysis
Mutations within the membrane proximal region of the Env-CT
were generated in the backbone of the proviral construct pNL4–3BH10env (Wilk et al., 1992), referred to here as pNL-Wt, by standard
PCR procedures and conﬁrmed by sequencing. Nucleotide num-
bering given here is from pNL4-3 (Adachi et al., 1986) and Env
amino acid (aa) numbering from strain BH10 Env (Ratner et al.,
1985). The aa mutated and the sequences of the mutagenising
oligonucleotides employed are given in Table 3. The nucleotide
changes in mutant pNL-Env-719–721-ILH do not affect the
sequence of the overlapping rev ORF. The oligonucleotide sequence
introducing a stop codon in the rev gene and thus expression of a
truncated Rev protein (Rev-Tr62) is also given in Table 3. It also
introduces a PvuII restriction site and three conservative aa
changes within the overlapping Env protein. The respective
proviral constructs with these mutations are designated pNL-
rev−− and pNL-Env-714–716-AAA-rev−−. The subviral construct,
referred to here as pLTR-ctat/crev, which expresses Tat and Rev
proteins from cDNAs has been described previously (Schaal et al.,
1993). pMD.G is an expression vector for the G glycoprotein of
vesicular stomatitis virus (VSV-G) (Naldini et al., 1996)Cells
HEK 293 T cells and Tzm-bl indicator cells were cultivated in
Dulbecco’s modiﬁed Eagle’s medium, 10% fetal calf serum (FCS)
and H9 T-cells in RPMI-1640 medium (Gibco), 10% FCS. Peripheral
blood mononuclear cells (PBMCs) from healthy donors were
puriﬁed by Ficoll-Hypaque gradient centrifugation (Keppler et al.,
2001). Several donors were pooled and activated at a density of
2×106 cells per ml in RPMI-1640 medium supplemented with 10%
FCS, glutamine (2 mM) and antibiotics (100 U/ml penicillin,
100 mg/ml streptomycin) together with 5 μg/ml PHA-P (Sigma)
and 100 U IL-2 (Biomol) for three days as previously described
(Baldauf et al., 2012). Afterwards, PMBCs were maintained in
medium lacking PHA-P.Analysis of viral proteins in cells and virions, cell–cell fusion activities
HEK 293 T cells were transfected with proviral constructs and,
at 48 h post-transfection (p.t.), cell lysates were prepared in gel
electrophoresis sample buffer (containing 2% SDS, 5% mercap-
toethanol) and aliquots of culture supernatants were stored at
−70 °C for further use. Preparation of virus particles from infected
H9 T-cells was performed as previously described (Emerson et al.,
T. Pfeiffer et al. / Virology 440 (2013) 31–40 392010; Holtkotte et al., 2007). Brieﬂy, VSV-G pseudotyped Wt and
mutant virions were generated in HEK 293 T cells by cotransfec-
tion of the respective proviral constructs with pMD.G. Aliquots of
culture supernatants, collected at 48 h p.t., were used to infect H9
T-cells. After removal of input virions and washing (at 5 h p. i.),
newly generated virion particles in the culture supernatants were
collected at 48 h p.i., concentrated by ultracentrifugation through
a cushion of 20% sucrose and lysed. Virion content in cell culture
supernatants and in concentrated virion preparations were quan-
tiﬁed by HIV p24-ELISA (Innogenetics, Belgium). Aliquots of cell
and virion lysates were subjected to Western blot analysis employ-
ing rabbit anti-gp120 serum, mouse anti-gp41 (Chessie 8) or anti-
p24 (183-H12-5C) as previously described (Emerson et al., 2010).
The abilities of the respective mutant Env proteins to mediate
membrane fusion between cells was evaluated in principle as
described previously (Holtkotte et al., 2006). Brieﬂy, transfected
HEK 293 T cells were cultivated with an approximately equal
number of Tzm-bl indicator cells and 3 h later, luciferase activities
(resulting from activation of the integrated HIV-LTR-luciferase
cassette in Tzm-bl cells) measured (Bosch et al., 2009). The
background on cocultivation of untransfected cells with Tzm-bl
cells was negligible.
Infections
Virion infection levels on indicator Tzm-bl cells were evaluated
as described previously (Bosch et al., 2009). Brieﬂy, wells of Tzm-bl
cells were infected in triplicate with doubling dilutions of virion-
containing supernatants, in the presence of HIV protease inhibitor
to prevent viral spread, and 48 h later, the cultures were ﬁxed and
stained for ß-galactosidase activity (from the integrated HIV-LTR-
ß-galactosidase cassette in Tzm-bl cells). The number of stained
cells, reﬂecting the number of infectious virions, were counted and
titres calculated. The abilities of the mutant virions to mediate
spreading infection in H9 T-cells were estimated as follows. Equal
amounts of cell-free virions in the supernatants of transfected HEK
293 T cells (as assessed by CA-ELISA) representing very limiting
amounts of infectious virus (MOI of pNL-Wt in H9 T-cells approx.
0.005) were employed to initiate infections. Infected cells were
ﬁxed on days 1, 2, 4, 6 and 7 p.i., stained with human anti-HIV
serum (patient serum) and the number of infected cells estimated
microscopically. Spreading infection was considered to have
occurred when 100% of the H9 T-cells were stained positive
on day 7.
2×105 activated PBMCs in 200 μl medium containing IL-2 were
infected with aliquots of supernatants of transfected HEK 293 T
cells (equalized by p24-ELISA), representing, in the case of pNL-
Wt, an MOI of 0.1 as measured by an infectivity assay on Tzm-bl
cells. Infected PBMCs were washed 19 h p.i. with an excess of
medium and taken up in 250 μl fresh medium containing IL-2.
Aliquots (50 μl) of the supernatants were collected immediately
(day 1) and stored at −−70 °C. The cultures were fed with a further
50 μl fresh medium containing IL-2 and cultured for a further
8 days. On days 2, 5, 6, 7 and 9, further 50 μl aliquots were
collected and the cultures refed with 50 μl fresh medium contain-
ing IL-2. Quantiﬁcation of released virions was achieved by
analysis of HIV reverse transcriptase activities in the media using
a one-step PCR-based assay as described (Pizzato et al., 2009).
Brieﬂy, supernatants and controls were lysed in 2× lysis buffer,
followed by further dilutions in 1× dilution buffer prior to PCR
analysis. A SYBR-Green I (Invitrogen)-based master mix including
MS2 RNA (Roche) and MS2-speciﬁc primers (forward: 5′
TCCTGCTCAACTTCCTGTCGAG 3′; reverse: 5′CACAGGTCAAACCTCC-
TAGGAATG 3′) were used to quantify HIV-1 reverse transcriptase
activity in the supernatants with the following PCR parameters:
42 °C for 20 min, 95 °C for 2 min, 40 cycles at 95° for 5 s, 60 °C for5 s, 72 °C for 15 s and 80 °C for 7 s (acquisition step) followed by
melting curve analysis. Data acquisition and analysis were per-
formed using Biorad CFX96 and Biorad CFX Manager software.
Semi-quantitative RT-PCR analysis of viral mRNAs
Total-RNA was isolated from HEK 293 T cells transiently
transfected with the respective proviral constructs at 24 h p. t.
by acid guanidinium thiocyanate–phenol–chloroform extraction
(Chomczynski and Sacchi, 1987). For reverse transcription 5 μg of
total RNA were digested with 10 U of DNase I (Roche). DNase was
subsequently heat-inactivated and cDNA synthesis performed
using 200 U Superscript III RNAse H–Reverse Transcriptase (Invi-
trogen), 7.5 pmol oligo(dT)12–18 (Invitrogen), 20 U of RNAsin
(Promega) and 10 mM of each deoxynucleoside triphosphate
(Qiagen). The cDNA was subsequently subjected to PCR analysis
using primer pairs 5′ CTT GAA AGC GAA AGT AAA GC 3′ (#1544,
nucleotides 653–672) and 5′ CGT CCC AGA TAA GTG CTA AGG 3′
(#3392, nucleotides 8469–8489) for the ampliﬁcation of intronless
2 kb mRNA species and #1544 and 5′ CAA TAC TAC TTC TTG TGG
GTT GG 3′ (#640, nucleotides 6456–6478) for intron-containing
4 kb mRNA species, respectively. RT-PCR products were separated
by polyacrylamide gel electrophoresis and stained with ethidium
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